ScreenerHero

SIMRIS-B Simris Group AB (PUBL)

STO · SE · Healthcare · Biotechnology · simrisgroup.com
0.1155SEK-9.77%Mkt Cap: 16.53M $P/E: —

Simris Group AB (PUBL), a biotechnology company, develops antibody-drug conjugate (ADC) payloads in Sweden and internationally. The company develops, manufactures, and sells bioactive substances from cultured microalgae …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap16.53M USD
Enterprise Value13.70M USD
Revenue (TTM)132.86K USD
Gross Profit168.83K USD
Net Income (TTM)-2.56M USD
Revenue/Share0.0010 SEK
Last Price0.1155 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees5
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-11.06
EV/Revenue103.09
P/S108.84
P/B112.00
EPS (TTM)-0.03
EPS (Forward)—
52W Range
0.040249% of range0.1950
52W High0.1950 SEK
52W Low0.0402 SEK
Profitability
Gross Margin109.29%
Oper. Margin-2773.98%
EBITDA Margin0.00%
Profit Margin-1660.12%
ROE5704.47%
ROA-18.07%
Growth
Revenue Growth-71.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.53M USD
CapEx (TTM)21.43K USD
FCF Margin-1192.75%
FCF Yield-9.59%
Net Debt-763.97K USD
Net Debt/EBITDA0.62
Balance Sheet
Debt/Equity-5.44
Current Ratio0.81
Quick Ratio0.71
Book Value/Sh0.0010 SEK
Cash/Share0.0060 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.35B
Float1.26B
Insiders4.12%
Institutions1.28%
Technical
SMA 500.1057 (+9.3%)
SMA 2000.0937 (+23.3%)
Beta0.88
S&P 52W Chg16.45%
Avg Vol (30d)181.05K
Avg Vol (10d)108.72K
Technical Indicators
RSI (14)59.3
MACD0.0045
MACD Signal0.0034
MACD Hist.+0.0010
BB Upper0.1326 SEK
BB Middle0.1120 SEK
BB Lower0.0914 SEK
BB Width36.74%
ATR (14)0.0163 SEK
Vol Ratio (20d)3.01x